Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Feb 24, 2012 (15 years ago)

Thyro-Tab.075 mg.

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Subpotent (Single Ingredient Drug): Low assay at the 6-month test interval.

Cause type: Wrong potency / content

Sub- or super-potent product, or a failed content-uniformity / assay test. You may receive too little or too much active ingredient - a direct dosing risk. All wrong potency / content recalls.

What was recalled

Thyro-Tab.075 mg., packaged in bulk drums for repackaging. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, Iowa 51601.

Recalling firm
Lloyd Inc
Origin
IA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1395-2012 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other recalls by Lloyd Inc

All 2012 recalls
Class II · Moderate risk

Levothroid

Subpotent (Single Ingredient Drug): Low assay at the 6-month test interval.

Terminated Wrong potency / content Lloyd Inc NDC 0456-1322-01 D-1394-2012
Class II · Moderate risk

Levothroid

Subpotent (Single Ingredient Drug): Low assay at the 9-month test interval.

Terminated Wrong potency / content Lloyd Inc NDC 0456-1321-01 D-1393-2012

Other wrong potency / content recalls from 2012

All wrong potency / content recalls